1
|
Sarıkaya Uzan G, Vural A, Yüksel D, Aksoy E, Öztoprak Ü, Canpolat M, Öztürk S, Yıldırım Ç, Güleç A, Per H, Gümüş H, Okuyaz Ç, Çobanoğulları Direk M, Kömür M, Ünalp A, Yılmaz Ü, Bektaş Ö, Teber S, Aliyeva N, Olgaç Dündar N, Gençpınar P, Gürkaş E, Keskin Yılmaz S, Kanmaz S, Tekgül H, Aksoy A, Öz Tuncer G, Acar Arslan E, Tosun A, Ayanoğlu M, Kızılırmak AB, Yousefi M, Bodur M, Ünay B, Hız Kurul S, Yiş U. Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study. Pediatr Neurol 2023; 145:3-10. [PMID: 37245275 DOI: 10.1016/j.pediatrneurol.2023.04.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Revised: 03/31/2023] [Accepted: 04/22/2023] [Indexed: 05/30/2023]
Abstract
BACKGROUND To evaluate the clinical features, demographic features, and treatment modalities of pediatric-onset chronic inflammatory demyelinating polyneuropathy (CIDP) in Turkey. METHODS The clinical data of patients between January 2010 and December 2021 were reviewed retrospectively. The patients were evaluated according to the Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society Guideline on the management of CIDP (2021). In addition, patients with typical CIDP were divided into two groups according to the first-line treatment modalities (group 1: IVIg only, group 2: IVIg + steroid). The patients were further divided into two separate groups based on their magnetic resonance imaging (MRI) characteristics. RESULTS A total of 43 patients, 22 (51.2%) males and 21 (48.8%) females, were included in the study. There was a significant difference between pretreatment and post-treatment modified Rankin scale (mRS) scores (P < 0.05) of all patients. First-line treatments include intravenous immunoglobulin (IVIg) (n = 19, 44.2%), IVIg + steroids (n = 20, 46.5%), steroids (n = 1, 2.3%), IVIg + steroids + plasmapheresis (n = 1, 2.3%), and IVIg + plasmapheresis (n = 1, 2.3%). Alternative agent therapy consisted of azathioprine (n = 5), rituximab (n = 1), and azathioprine + mycophenolate mofetil + methotrexate (n = 1). There was no difference between the pretreatment and post-treatment mRS scores of groups 1 and 2 (P > 0.05); however, a significant decrease was found in the mRS scores of both groups with treatment (P < 0.05). The patients with abnormal MRI had significantly higher pretreatment mRS scores compared with the group with normal MRI (P < 0.05). CONCLUSIONS This multicenter study demonstrated that first-line immunotherapy modalities (IVIg vs IVIg + steroids) had equal efficacy for the treatment of patients with CIDP. We also determined that MRI features might be associated with profound clinical features, but did not affect treatment response.
Collapse
Affiliation(s)
- Gamze Sarıkaya Uzan
- Division of Child Neurology, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
| | - Atay Vural
- Koç University Research Center for Translational Medicine (KUTTAM), İstanbul, Turkey; Department of Neurology, Koç University School of Medicine, İstanbul, Turkey
| | - Deniz Yüksel
- Faculty of Medicine, Department of Pediatric Neurology, Dr. Sami Ulus Maternity Child Health and Diseases Training and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - Erhan Aksoy
- Faculty of Medicine, Department of Pediatric Neurology, Dr. Sami Ulus Maternity Child Health and Diseases Training and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - Ülkühan Öztoprak
- Faculty of Medicine, Department of Pediatric Neurology, Dr. Sami Ulus Maternity Child Health and Diseases Training and Research Hospital, University of Health Sciences, Ankara, Turkey
| | - Mehmet Canpolat
- Division of Child Neurology, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey
| | - Selcan Öztürk
- Division of Child Neurology, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey
| | - Çelebi Yıldırım
- Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey
| | - Ayten Güleç
- Division of Child Neurology, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey
| | - Hüseyin Per
- Division of Child Neurology, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey
| | - Hakan Gümüş
- Division of Child Neurology, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey
| | - Çetin Okuyaz
- Division of Child Neurology, Department of Pediatrics, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Meltem Çobanoğulları Direk
- Division of Child Neurology, Department of Pediatrics, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Mustafa Kömür
- Division of Child Neurology, Department of Pediatrics, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Aycan Ünalp
- Division of Pediatric Neurology, Department of Pediatrics, University of Health Sciences Dr. Behçet Uz Child Disease and Pediatric Surgery Training and Research Hospital, Izmir, Turkey
| | - Ünsal Yılmaz
- Division of Pediatric Neurology, Department of Pediatrics, University of Health Sciences Dr. Behçet Uz Child Disease and Pediatric Surgery Training and Research Hospital, Izmir, Turkey
| | - Ömer Bektaş
- Division of Child Neurology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Serap Teber
- Division of Child Neurology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Nargiz Aliyeva
- Division of Pediatric Neurology, Department of Pediatrics, University of Health Sciences Tepecik Research and Training Hospital, İzmir, Turkey
| | - Nihal Olgaç Dündar
- Division of Child Neurology, Department of Pediatrics, İzmir Katip Çelebi University Faculty of Medicine, İzmir, Turkey
| | - Pınar Gençpınar
- Division of Child Neurology, Department of Pediatrics, İzmir Katip Çelebi University Faculty of Medicine, İzmir, Turkey
| | - Esra Gürkaş
- Department of Pediatric Neurology, Children's Hospital, Ankara City Hospital, Ankara, Turkey
| | - Sanem Keskin Yılmaz
- Division of Child Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey
| | - Seda Kanmaz
- Division of Child Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey
| | - Hasan Tekgül
- Division of Child Neurology, Department of Pediatrics, Ege University Faculty of Medicine, İzmir, Turkey
| | - Ayşe Aksoy
- Division of Child Neurology, Department of Pediatrics, On Dokuz Mayıs University Faculty of Medicine, Samsun, Turkey
| | - Gökçen Öz Tuncer
- Division of Child Neurology, Department of Pediatrics, On Dokuz Mayıs University Faculty of Medicine, Samsun, Turkey
| | - Elif Acar Arslan
- Division of Child Neurology, Department of Pediatrics, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey
| | - Ayşe Tosun
- Division of Child Neurology, Department of Pediatrics, Adnan Menderes University Faculty of Medicine, Aydın, Turkey
| | - Müge Ayanoğlu
- Division of Child Neurology, Department of Pediatrics, Adnan Menderes University Faculty of Medicine, Aydın, Turkey
| | - Ali Burak Kızılırmak
- Koç University Research Center for Translational Medicine (KUTTAM), İstanbul, Turkey
| | - Mohammadreza Yousefi
- Koç University Research Center for Translational Medicine (KUTTAM), İstanbul, Turkey
| | - Muhittin Bodur
- Division of Child Neurology, Department of Pediatrics, Uludağ University Faculty of Medicine, Bursa, Turkey
| | - Bülent Ünay
- Gülhane Faculty of Medicine, Department of Pediatric Neurology, University of Health Sciences, Ankara, Turkey
| | - Semra Hız Kurul
- Division of Child Neurology, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey
| | - Uluç Yiş
- Division of Child Neurology, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey
| |
Collapse
|
2
|
Öksüz N, Kömür M, Doğu O. Treatment Dilemma in Juvenile Huntington's Patient Presenting with Psychiatric Symptoms. Noro Psikiyatr Ars 2023; 60:87-89. [PMID: 36911560 PMCID: PMC9999214 DOI: 10.29399/npa.28058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Accepted: 01/25/2022] [Indexed: 11/07/2022] Open
Abstract
The Westphal variant of Huntington's disease (HD) is a progressive neurodegenerative disease characterized by a rigid-hypokinetic syndrome rather than choreiform movements. This variant is a distinct clinical entity of HD and is often associated with a juvenile onset of the disease. We present the case of a 13-year-old patient diagnosed with the Westphal variant with an onset at approximately 7 years of age and primarily exhibited developmental delay and psychiatric symptoms. In the light of findings from both physical and clinical examinations, possible difficulties in the diagnosis and treatment of juvenile HD are discussed in here.
Collapse
Affiliation(s)
- Nevra Öksüz
- Mersin University School of Medicine, Department of Neurology, Mersin, Turkey
| | - Mustafa Kömür
- Mersin University School of Medicine, Department of Child Neurology, Mersin, Turkey
| | - Okan Doğu
- Mersin University School of Medicine, Department of Neurology, Mersin, Turkey
| |
Collapse
|
3
|
Öz Tunçer G, Sanri A, Aydin S, Hergüner ÖM, Özgün N, Kömür M, İçağasioğlu DF, Toker RT, Yilmaz S, Arslan EA, Güngör M, Kutluk G, Erol İ, Mert GG, Polat BG, Aksoy A. Clinical and Genetic Spectrum of Myotonia Congenita in Turkish Children. J Neuromuscul Dis 2023; 10:915-924. [PMID: 37355912 PMCID: PMC10578252 DOI: 10.3233/jnd-230046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/02/2023] [Indexed: 06/26/2023]
Abstract
BACKGROUND Myotonia congenita is the most common form of nondystrophic myotonia and is caused by Mendelian inherited mutations in the CLCN1 gene encoding the voltage-gated chloride channel of skeletal muscle. OBJECTIVE The study aimed to describe the clinical and genetic spectrum of Myotonia congenita in a large pediatric cohort. METHODS Demographic, genetic, and clinical data of the patients aged under 18 years at time of first clinical attendance from 11 centers in different geographical regions of Türkiye were retrospectively investigated. RESULTS Fifty-four patients (mean age:15.2 years (±5.5), 76% males, with 85% Becker, 15% Thomsen form) from 40 families were included. Consanguineous marriage rate was 67%. 70.5% of patients had a family member with Myotonia congenita. The mean age of disease onset was 5.7 (±4.9) years. Overall 23 different mutations (2/23 were novel) were detected in 52 patients, and large exon deletions were identified in two siblings. Thomsen and Becker forms were observed concomitantly in one family. Carbamazepine (46.3%), mexiletine (27.8%), phenytoin (9.3%) were preferred for treatment. CONCLUSIONS The clinical and genetic heterogeneity, as well as the limited response to current treatment options, constitutes an ongoing challenge. In our cohort, recessive Myotonia congenita was more frequent and novel mutations will contribute to the literature.
Collapse
Affiliation(s)
- Gökçen Öz Tunçer
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Türkiye
| | - Aslıhan Sanri
- Department of Pediatric Genetics, University of Health Sciences, Samsun Training and Research Hospital, Samsun, Türkiye
| | - Seren Aydin
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Türkiye
| | - Özlem M. Hergüner
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Çukurova University, Adana, Türkiye
| | - Nezir Özgün
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Artuklu University, Mardin, Türkiye
| | - Mustafa Kömür
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Mersin University, Mersin, Türkiye
| | - Dilara F. İçağasioğlu
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Bezmialem Vakıf University, İstanbul, Türkiye
| | - Rabia Tütüncü Toker
- Department of Pediatric Neurology, University of Health Sciences, Bursa City Hospital, Bursa, Türkiye
| | - Sanem Yilmaz
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Ege University, İzmir, Türkiye
| | - Elif Acar Arslan
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye
| | - Mesut Güngör
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye
| | - Gültekin Kutluk
- Department of Pediatric Neurolgy, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Türkiye
| | - İlknur Erol
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Başkent University, Adana, Türkiye
| | - Gülen Gül Mert
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Çukurova University, Adana, Türkiye
| | - Burçin Gönüllü Polat
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Mersin University, Mersin, Türkiye
| | - Ayşe Aksoy
- Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Türkiye
| |
Collapse
|
4
|
Fogarasi A, Fazzi E, Smorenburg ARP, Mazurkiewicz-Beldzinska M, Dinopoulos A, Pobiecka A, Schröder-van den Nieuwendijk D, Kraus J, Tekgül H, Kraus J, Dinopoulos A, Koutsaki M, Fogarasi A, Baranello G, Bertoli S, Caramaschi E, Cordelli DM, De Amicis R, Fazzi E, Forchielli ML, Guerra A, Lividini A, Marchiò M, Rossi A, Nieuwendijk DSVD, Fliciński J, Gurda B, Lemska A, Matheisel A, Mazurkiewicz-Beldzinska M, Niwinska Z, Pawłowicz M, Sawicka A, Steinborn B, Szmuda M, Winczewska-Wiktor A, Zawadzka M, Pobiecka A, Arhan E, Aydin K, Bayram E, Carman KB, Edem P, Ertem D, Goktas ÖA, Gungor S, Haliloglu G, Kansu A, Kömür M, Mutlu A, Kırsaçlıoğlu CT, Okuyaz Ç, Özgör B, Ozturk Y, Sager SG, Sarıgeçili E, Selimoglu MA, Serin HMÖ, Teber ST, Tekgül H, Thomas G, Turkdogan D, Volkan B, Yarar C, Yilmaz SK. The PURPLE N study: objective and perceived nutritional status in children and adolescents with cerebral palsy. Disabil Rehabil 2022; 44:6668-6675. [PMID: 34473588 DOI: 10.1080/09638288.2021.1970255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
PURPOSE To obtain information on characteristics, management, current objective nutritional status and perception of nutritional status of children with cerebral palsy (CP) from healthcare professionals (HCPs) and caregivers. MATERIALS AND METHODS A detailed survey of several items on eight main topics (general characteristics, motor function, comorbidities, therapies, anthropometry, feeding mode and problems and perceived nutritional status) was developed and tested for the study. Correlation between nutritional status and Gross Motor Function Classification System (GMFCS) levels was assessed using continuous variables (Z-scores for weight-for-age, height-for-age, weight-for-height, and body mass index-for-age), and categorical variables (being malnourished, stunted, or wasted). HCP and caregiver perceptions of the child's nutritional status as well as agreement between perceived and objective nutritional status and agreement between perceived nutritional status and concerns about the nutritional status were analyzed. RESULTS Data were available for 497 participants from eight European countries. Poorer nutritional status was associated with higher (more severe) GMFCS levels. There was minimal agreement between perceived and objective nutritional status, both for HCPs and caregivers. Agreement between HCP and caregiver perceptions of the child's nutritional status was weak (weighted kappa 0.56). However, the concerns about the nutritional status of the child were in line with the perceived nutritional status. CONCLUSIONS The risk of poor nutritional status is associated with more severe disability in children and adolescents with CP. There is a mismatch between HCP and caregiver perceptions of participants' nutritional status as well as between subjective and objective nutritional status. Our data warrant the use of a simple and objective screening tool in daily practice to determine nutritional status in children and adolescents with CP. Clinical trial registration: ClinicalTrials.gov Identifier: NCT03499288 (https://clinicaltrials.gov/ct2/show/NCT03499288). IMPLICATIONS FOR REHABILITATIONUse of the ESPGHAN recommendations and simple screening tools in daily practice is needed to improve nutritional care for individuals with CP.Attention should be paid to the differences in the perception of nutritional status of individuals with CP between professionals and caregivers to improve appropriate referral for nutritional support.Objective measures rather than the professional's perception need to be used to define the nutritional status of individuals with CP.
Collapse
Affiliation(s)
- Andras Fogarasi
- Child Neurology Department, Bethesda Children's Hospital, Budapest, Hungary
| | - Elisa Fazzi
- Unit of Child Neurology and Psychiatry, ASST Spedali Civili, Brescia, Italy.,Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | - Ana R P Smorenburg
- Department of Specialized Nutrition, Danone Nutricia Research, Utrecht, The Netherlands
| | | | - Argirios Dinopoulos
- 3rd Department of Pediatrics, Attikon General Hospital, University of Athens, Athens, Greece
| | - Alena Pobiecka
- Department of Pediatrics, University Hospital Trnava, Slovakia
| | | | - Josef Kraus
- Department of Child Neurology, University Hospital Motol, Czech Republic
| | - Hasan Tekgül
- Ege University School of Medicine, Pediatric Neurology, Izmir, Turkey
| | | | | | - Josef Kraus
- Department of Child Neurology, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
| | | | - Argirios Dinopoulos
- Pediatric Neurology Unit, 3rd Department of Pediatrics, University of Athens, Attikon General Hospital, Athens
| | - Maria Koutsaki
- Pediatric Neurology Unit, 3rd Department of Pediatrics, University of Athens, Attikon General Hospital, Athens
| | | | | | | | | | - Simona Bertoli
- International Center for the Assessment of Nutritional Status (ICANS), Department of Food Environmental and Nutritional Sciences (DeFENS), University of Milan
| | - Elisa Caramaschi
- Department of Medical and Surgical Sciences of Mother, Children and Adults, Pediatric Unit, University of Modena and Reggio Emilia, Modena
| | - Duccio Maria Cordelli
- Child Neurology and Psychiatry Unit, Department of Medical and Surgical Sciences (DIMEC), S. Orsola Hospital, University of Bologna
| | - Ramona De Amicis
- International Center for the Assessment of Nutritional Status (ICANS), Department of Food Environmental and Nutritional Sciences (DeFENS), University of Milan
| | - Elisa Fazzi
- ASST Spedali Civili, Brescia, and University of Brescia, Brescia, Italy
| | - Maria Luisa Forchielli
- Pediatric Gastroenterology and Nutrition Clinic, AO Sant'Orsola - Malpighi, University of Bologna
| | - Azzurra Guerra
- Pediatric Unit, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena
| | - Althea Lividini
- Child Neurology and Psychiatry Unit, S. Orsola Hospital, University of Bologna
| | - Maddalena Marchiò
- Pediatric Unit, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena
| | - Andrea Rossi
- Child and Adolescent Neurology and Psychiatry Unit, Children Hospital, ASST Spedali Civili - Brescia
| | | | | | | | - Jędrzej Fliciński
- Chair and Department of Developmental Neurology, Poznan University of Medical Sciences
| | - Barbara Gurda
- Chair and Department of Developmental Neurology, Poznan University of Medical Sciences
| | - Anna Lemska
- Department of Developmental Neurology, Medical University of Gdańsk
| | | | | | - Zuzanna Niwinska
- Chair and Department of Developmental Neurology, Poznan University of Medical Sciences
| | - Małgorzata Pawłowicz
- Department of Developmental Neurology, Medical University of Gdańsk.,(current affiliations: Department of Pediatric Neurology.,Provincial Specialist Children's Hospital in Olsztyn, Olsztyn.,Department of Pathophysiology, Faculty of Medicine, Warmia and Mazury University in Olsztyn, Olsztyn, Poland)
| | | | - Barbara Steinborn
- Chair and Department of Developmental Neurology, Poznan University of Medical Sciences
| | - Marta Szmuda
- Department of Developmental Neurology, Medical University of Gdańsk
| | | | - Marta Zawadzka
- Department of Developmental Neurology, Medical University of Gdańsk
| | | | - Alena Pobiecka
- Department of Pediatrics, University Hospital Trnava, Slovakia
| | | | - Ebru Arhan
- Gazi University School of Medicine/Neurology, Gazi
| | - Kursad Aydin
- Gazi University, School of Medicine, Pediatric Neurology, Ankara
| | - Erhan Bayram
- Dokuz Eylul University School of Medicine, Pediatric Neurology, Izmir
| | - Kursat Bora Carman
- Division of Pediatric Intensive Care Unit, Eskişehir Osmangazi University Medical Faculty
| | - Pinar Edem
- Dokuz Eylul University School of Medicine, Pediatric Neurology, Izmir
| | - Deniz Ertem
- Marmara University School of Medicine/Gastroenterology, Istanbul
| | | | - Serdal Gungor
- Inonu University School of Medicine/Neurology, Malatya
| | - Goknur Haliloglu
- Hacettepe University Faculty of Medicine, Department of Pediatric Neurology, Ankara
| | - Aydan Kansu
- Ankara University School of Medicine/Gastroenterology, Ankara
| | | | - Akmer Mutlu
- Hacettepe University, Faculty of Physical Therapy and Rehabilitation/Developmental and Early Physiotherapy Unit, Ankara
| | | | - Çetin Okuyaz
- Division of Pediatric Neurology, Faculty of Medicine, Mersin University, Mersin
| | - Bilge Özgör
- Inonu University School of Medicine, Malatya
| | - Yesim Ozturk
- Dokuzeylul University School of Medicine/Gastroenterology, Izmir
| | | | | | | | | | - Serap Tıraş Teber
- University of Ankara Faculty of Medicine, Department of Child Neurology, Ankara
| | - Hasan Tekgül
- Ege University School of Medicine, Pediatric Neurology, Izmir
| | - Gülten Thomas
- Marmara University School of Medicine/Gastroenterology, Istanbul
| | | | - Burcu Volkan
- Marmara University School of Medicine/Gastroenterology, Istanbul
| | - Coşkun Yarar
- Department of Pediatric Neurology, Eskişehir Osmangazi University School of Medicine, Eskişehir
| | | |
Collapse
|
5
|
Ipek R, Bozdogan ST, Kömür M, Okuyaz C. A Novel Mutation Diagnosing in Allan–Herndon–Dudley's Syndrome. J Pediatr Genet 2021. [DOI: 10.1055/s-0041-1740457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
AbstractAllan–Herndon–Dudley's syndrome (AHDS) is a rare X-linked recessive disease that causes abnormal serum thyroid function tests, severe hypotonia, intellectual disability, and motor deficit due to a mutation in the monocarboxylate transporter 8, which is a thyroid hormone transporter. A 6-month-old male patient presented to our outpatient clinic with a serious hypotonia complaint. With a preliminary diagnosis of AHDS, a molecular genetic examination was performed. The molecular genetic analysis detected a new previously unidentified variant in the SLC16A2 gene. This case has been presented to report the AHDS, which is a rare cause of hypotonia in patients presenting/consulting with severe hypotonia, global developmental delay, and abnormal thyroid function test results. Besides, a novel pathogenic mutation in the SLC16A2 gene has been described in the present article.
Collapse
Affiliation(s)
- Rojan Ipek
- Department of Pediatrics, Division of Neurology, Training and Research Hospital, Adıyaman University, Adıyaman, Turkey
| | - Sevcan Tug Bozdogan
- Department of Medical Genetics, Medical Faculty, Çukurova University, Adana, Turkey
| | - Mustafa Kömür
- Department of Pediatrics, Division of Neurology, Medical Faculty, Mersin University, Mersin, Turkey
| | - Cetin Okuyaz
- Department of Pediatrics, Division of Neurology, Medical Faculty, Mersin University, Mersin, Turkey
| |
Collapse
|
6
|
Direk MÇ, Makharoblidze K, Sevimli E, Çelik Y, Taşdelen B, Kömür M, Okuyaz Ç. Long-term cognitive outcomes of prematurely born infants: A longitudinal follow-up of Denver II, Bayley III and WISC-IV Tests. Pediatr Int 2021; 63:1504-1509. [PMID: 33724609 DOI: 10.1111/ped.14697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2020] [Accepted: 03/02/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND Prematurity constitutes a risk factor for developmental delay in infancy and childhood. This study aims to: (i) determine long-term cognitive outcomes in prematurely delivered children and compare them with term-delivered children using the WISC-IV and Stroop tests; (ii) examine the relation between Denver II, Bayley III and WISC-IV, Stroop tests. METHODS The study group consisted of children born prematurely who had been tested with Denver II and Bayley III in their first 2 years, and had been evaluated with WISC-IV and Stroop tests under follow up, 6-10 years later. RESULTS The study group (n = 60, 25 F, 35 M) was 8.0 ± 2.4 (6-10.7) years old when given WISC-IV and Stroop tests. Gestational age in the study group was 34-37 weeks in 25%, 30-33 weeks in 48.3%, and <29 weeks in 26.7%. On WISC-IV, the verbal comprehension index, perceptual reasoning index, working memory index, and full-scale IQ scores were lower in the study group than the control group (P < 0.05). The study group took longer to complete the Stroop test (P < 0.05). Lower socioeconomic status (P = 0.005) and parental education level (P = 0.000) were associated with lower verbal comprehension index scores. Denver II and Bayley III test results were related to WISC-IV results (P < 0.05) but not to the Stroop test results (P > 0.05). CONCLUSIONS Our results showed prematurity negatively influences the results of WISC-IV and Stroop tests at school age. Denver II and Bayley III tests applied at age 2 years likely predict WISC-IV results.
Collapse
Affiliation(s)
| | - Khatuna Makharoblidze
- Department of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Eyşan Sevimli
- Department of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Yalçın Çelik
- Department of Neonatology Care Unit, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Bahar Taşdelen
- Department of Biostatistics, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Mustafa Kömür
- Department of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Çetin Okuyaz
- Department of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| |
Collapse
|
7
|
İpek R, Makharoblidze K, Polat BG, Direk MÇ, Yıldırım DD, Kömür M, Okuyaz Ç. Developmental evaluation in children experiencing febrile convulsions. Turk J Pediatr 2021; 63:602-611. [PMID: 34449142 DOI: 10.24953/turkjped.2021.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND The objective of this study was to determine the effect of febrile convulsion (FC) on neuromotor development. METHODS Data of 325 patients, who were followed up at our outpatient clinic and diagnosed with FC between January 2012 and December 2018, were retrospectively evaluated. Of these patients, 203 underwent the Denver Developmental Screening Test II (DDST II) and were included in the study as the patient group and 100 healthy children as the control group. RESULTS Of the study group, 84 (41.4%) were girls and 119 (58.6%) were boys (B/G: 1.4). Of all patients, 163 (80.3%) were diagnosed with simple FC, 22 (10.8%) with complicated FC, and 18 (8.9%) with FC+. There was no significant relationship found between FC subtypes and gender, family history of FC, family history of epilepsy, iron (Fe) deficiency, and Fe deficiency anemia. DDST II subtest points were significantly lower in all developmental areas in the patient group when compared to the controls (p < 0.001), while suspected and abnormal test results were higher in all developmental areas in the patient group compared to the controls (p=0.01). It was also determined that the language points were lower as the age of first seizure increased (r=- 0.319, p < 0.01). CONCLUSIONS Although FC is known to usually having a good prognosis, the low DDST II test results measured in this study indicated that the FC may pose a developmental risk and patients with FC should be followed up in terms of developmental features. Because of the retrospective nature of the study, there was no `preconvulsion` developmental evaluation. This is a major limitation of our study.
Collapse
Affiliation(s)
- Rojan İpek
- Departments of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Khatuna Makharoblidze
- Departments of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Burçin Gönüllü Polat
- Departments of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| | | | | | - Mustafa Kömür
- Departments of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| | - Çetin Okuyaz
- Departments of Pediatric Neurology, Mersin University Faculty of Medicine, Mersin, Turkey
| |
Collapse
|
8
|
Tok Umay S, Özgür A, Görür K, Kömür M, Balcı Y. Axial Mesodermal Dysplasia Complex with a Unique Abnormal Course of Vestibulocochlear Nerve. J Int Adv Otol 2018; 15:317-320. [PMID: 30431015 DOI: 10.5152/iao.2018.5830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Axial mesodermal dysplasia complex (AMDC) is a combination of multiple congenital malformations arising due to the mesodermal cell migration, neural tube fusion, and rhombencephalon segmentation. Here, we present the imaging findings of a 15-year-old boy with AMDC who has bilateral inner ear malformations associated with a vestibulocochlear nerve extending to Meckel cave, cystic lesion in prepontine cisterna, cervical vertebral segmentation anomalies, and maxillar bone anomalies.
Collapse
Affiliation(s)
- Sermin Tok Umay
- Department of Radiology, Mersin University School of Medicine, Mersin, Turkey
| | - Anıl Özgür
- Department of Radiology, Mersin University School of Medicine, Mersin, Turkey
| | - Kemal Görür
- Department of Otolaryngology-Head and Neck Surgery, Mersin University School of Medicine, Mersin, Turkey
| | - Mustafa Kömür
- Department of Pediatrics, Mersin University School of Medicine, Mersin, Turkey
| | - Yüksel Balcı
- Department of Radiology, Mersin University School of Medicine, Mersin, Turkey
| |
Collapse
|
9
|
Tolunay O, Çelik T, Çelik Ü, Kömür M, Tanyeli Z, Sönmezler A. Concurrency of Guillain-Barre syndrome and acute transverse myelitis: a case report and review of literature. Korean J Pediatr 2016; 59:S161-S164. [PMID: 28018472 PMCID: PMC5177703 DOI: 10.3345/kjp.2016.59.11.s161] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/13/2014] [Revised: 01/03/2015] [Accepted: 01/27/2015] [Indexed: 12/14/2022]
Abstract
Guillain-Barré syndrome and acute transverse myelitis manifest as demyelinating diseases of the peripheral and central nervous system. Concurrency of these two disorders is rarely documented in literature. A 4-year-old girl presenting with cough, fever, and an impaired walking ability was admitted to hospital. She had no previous complaints in her medical history. A physical examination revealed lack of muscle strength of the lower extremities and deep tendon reflexes. MRI could not be carried out due to technical problems; therefore, both Guillain-Barré syndrome and acute transverse myelitis were considered for the diagnosis. Intravenous immunoglobulin treatment was started as first line therapy. Because this treatment did not relieve the patient's symptoms, spinal MRI was carried out on the fourth day of admission and demyelinating areas were identified. Based on the new findings, the patient was diagnosed with acute transverse myelitis, and high dose intravenous methylprednisolone therapy was started. Electromyography findings were consistent with acute polyneuropathy affecting both motor and sensory fibers. Therefore, the patient was diagnosed with concurrency of Guillain-Barré syndrome and acute transverse myelitis. Interestingly, while concurrency of these 2 disorders is rare, this association has been demonstrated in various recent publications. Progress in diagnostic tests (magnetic resonance imaging and electrophysiological examination studies) has enabled clinicians to establish the right diagnosis. The possibility of concurrent Guillain-Barré syndrome and acute transverse myelitis should be considered if recovery takes longer than anticipated.
Collapse
Affiliation(s)
- Orkun Tolunay
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Tamer Çelik
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Ümit Çelik
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Mustafa Kömür
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Zeynep Tanyeli
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Abdurrahman Sönmezler
- Department of Neurology, Adana Numune Training and Research Hospital, Turkey and Research Hospital, Adana, Turkey
| |
Collapse
|
10
|
Çelik T, Çelik Ü, Tolunay O, Kömür M, Başpınar H, Yılmaz C, Mert G, Yıldızdaş D. Epstein-Barr virus encephalitis with substantia nigra involvement. J Pediatr Neurosci 2016; 10:401-3. [PMID: 26962357 PMCID: PMC4770663 DOI: 10.4103/1817-1745.174436] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Infectious mononucleosis due to Epstein-Barr virus (EBV) is a usually benign systemic viral illness common in children. Many studies described nervous system manifestations of infectious mononucleosis with a wide spectrum of neurologic deficits. Neurologic complications of EBV are seen in both acute and reactivate infection. Herein, we describe a patient diagnosed by acute EBV encephalitis with substantia nigra involvement and excellent clinical recovery.
Collapse
Affiliation(s)
- Tamer Çelik
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Ümit Çelik
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Orkun Tolunay
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Mustafa Kömür
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Hüseyin Başpınar
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Cengiz Yılmaz
- Department of Radiology, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Gülen Mert
- Department of Pediatrics, Cukurova University School of Medicine, Adana, Turkey
| | - Dinçer Yıldızdaş
- Department of Pediatrics, Cukurova University School of Medicine, Adana, Turkey
| |
Collapse
|
11
|
Celik T, Celik U, Kömür M, Tolunay O, Yildizdas RD, Yagci-Kupeli B, Kücük F, Eroglu İ. Pediatric Lyme Neuroborreliosis: Different clinical presentations of the same agent; Single center experience. Neuro Endocrinol Lett 2016; 37:107-113. [PMID: 27179572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 03/15/2016] [Accepted: 04/05/2016] [Indexed: 06/05/2023]
Abstract
OBJECTIVES Lyme disease is a vector-associated infectious disease, caused by the agent, spirochete Borrelia burgdorferi. Neurologic findings are observed in approximately 12% of the cases and termed Lyme neuroborreliosis (LNB). Lyme neuroborreliosis may manifest with different clinical neurologic manifestations. METHODS The study was conducted at tertiary training and research hospital. From January 2014 to September 2015, a total of 75 patients diagnosed with encephalitis, ataxia, Guillain Barre Syndrome (GBS), facial paralysis, acute disseminated encephalomyelitis (ADEM), pseudotumorcerebri were evaluated for inclusion to the study. Among these patients whom investigations of B. burgdorferi antibody IgM and/or IgG ELISA and Western Blot (WB) were detected to be positive, were assessed. Epidemiologic data, tick bite histories, duration of symptoms, clinical findings, radiologic findings, treatment durations and prognosis were investigated. RESULTS Totally 7 patients had been treated with the diagnosis of Lyme neuroborreliosis. The mean age was 9.14±4.91 years; duration of symptoms before admission was 8.0±4.50 days; and the duration of antibiotic use was 2.85±0.89 weeks. All patients had received ceftriaxone and intravenous immunoglobulin (IVIG); 3 patients had received plasmapheresis (42.9%) and one patient had received pulse corticosteroid therapy. While the patient with the diagnosis of encephalomyeloneuritis and atypical GBS had partially improved, the other patients were completely cured. CONCLUSION In this article, we report pediatric LNB patients, B. burgdorferi should also be considered in patients with atypical or severe neurologic involvement or a history of tick bite; it is known that the prognosis is good with appropriate and early treatment.
Collapse
Affiliation(s)
- Tamer Celik
- Pediatric Neurology, Adana Numune Research and Training Hospital, Turkey
| | - Umit Celik
- Pediatric Infection, Adana Numune Research and Training Hospital, Turkey
| | - Mustafa Kömür
- Pediatric Neurology, Adana Numune Research and Training Hospital, Turkey
| | - Orkun Tolunay
- Department of Pediatrics, Adana Numune Research and Training Hospital, Turkey
| | | | | | - Fulya Kücük
- Department of Pediatrics, Adana Numune Research and Training Hospital, Turkey
| | - İsmail Eroglu
- Department of Pediatrics, Adana Numune Research and Training Hospital, Turkey
| |
Collapse
|
12
|
Tolunay O, Celik T, Celik U, Kömür M, Yagci-Kupeli B. Cerebral salt wasting in pediatric critical care; not just a neurosurgical disorder anymore. Neuro Endocrinol Lett 2015; 36:578-582. [PMID: 26812288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Received: 11/10/2015] [Accepted: 11/23/2015] [Indexed: 06/05/2023]
Abstract
OBJECTIVE Cerebral salt-wasting syndrome (CSWS) is a hypovolemic hyponatremia caused by natriuresis and diuresis, of which the exact pathogenesis is unknown. Although CSWS has been more commonly described to be associated with neurosurgical disorders, increasing numbers of patients are diagnosed and new etiological factors are being identified as the awareness of it increases. METHODS The files of the patients who had been hospitalized and treated with the diagnosis of CSWS at the pediatric critical care unit during the last three years were retrospectively reviewed. RESULTS Totally 9 patients had been treated with the diagnosis of CSWS. The causes of CSWS were identified as tuberculosis meningitis in two patients, status epilepticus in two patients, ketamine infusion in one patient, medulloblastoma in one patient, sepsis in one patient, brain oedema following child abuse in one patient, and cerebral infarct in one patient. All of the patients had received isotonic saline and hypertonic saline while 77.7% of them had received fludrocortisone. The mean time to correction of hyponatremia was 20.37±14.73 days. One patient had died. CONCLUSION Cerebral salt-wasting syndrome is increasingly described in the etiology of hyponatremia that is commonly seen in children hospitalized especially at critical care units. Serum sodium, urinary sodium and polyuria should be primarily considered in the diagnosis, and supportive laboratory tests such as uric acid and brain natriuretic peptide (BNP) should not be stipulated. At hospitals providing inpatient care services, clinical and laboratory characteristics of CSWS should be known in detail especially at pediatric critical care units.
Collapse
Affiliation(s)
- Orkun Tolunay
- Department of Pediatrics, Adana Numune Research and Training Hospital, Turkey
| | - Tamer Celik
- Pediatric Neurology, Adana Numune Research and Training Hospital, Turkey
| | - Umit Celik
- Pediatric Infection, Adana Numune Research and Training Hospital, Turkey
| | - Mustafa Kömür
- Pediatric Infection, Adana Numune Research and Training Hospital, Turkey
| | | |
Collapse
|
13
|
Abstract
INTRODUCTION Alpha lipoic acid is a powerful antioxidant widely used for the supplementary treatment of diabetic neuropathy. Intoxication with alpha lipoic acid is very rare. There is no reported dose of safety in children. CASE REPORT A 14-month-old previously healthy girl was referred to our hospital with the diagnosis of drug intoxication. She was admitted to the emergency department with lethargy and continuing involuntary movements for several hours after she had ingested an unknown amount of alpha lipoic acid. On admission she was lethargic and had myoclonic seizures involving all extremities. She had no fever and laboratory examinations were normal except for mild metabolic acidosis. The seizures were unresponsive to bolus midazolam, phenytoin infusion and levetiracetam infusion. She was taken to the pediatric intensive care unit with the diagnosis of status epilepticus. After failure of the treatment with midazolam infusion she was intubated and thiopental sodium infusion was started. Her myoclonic seizures were controlled with thiopental sodium infusion. After 48 h intubation and mechanical ventilation thiopental sodium was gradually reduced and then stopped. Following the withdraw of thiopental sodium, she was seizure free on her discharge on the 8th day. CONCLUSION Alpha lipoic acid and derivatives cause side effects in children like refractory convulsions. They are frequently rendered as vitamins by diabetic patients and are left at places where children can easily access them. Therefore, when faced with refractory convulsions in children who have had no disease before, intoxication by medicaments with alpha lipoic acid should be taken into consideration.
Collapse
Affiliation(s)
- Orkun Tolunay
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey.
| | - Tamer Çelik
- Department of Pediatric Neurology, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Mustafa Kömür
- Department of Pediatric Neurology, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Ali Emre Gezgin
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Musa Soner Kaya
- Department of Pediatrics, Adana Numune Training and Research Hospital, Adana, Turkey
| | - Ümit Çelik
- Department of Pediatric infection, Adana Numune Training and Research Hospital, Adana, Turkey
| |
Collapse
|
14
|
Çelik T, Çelik Ü, Kömür M, Tolunay O, Dönmezer Ç, Yıldızdas D. Treatment of Lyme neuroborreliosis with plasmapheresis. J Clin Apher 2015; 31:476-8. [DOI: 10.1002/jca.21430] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2014] [Revised: 08/07/2015] [Accepted: 08/12/2015] [Indexed: 11/08/2022]
Affiliation(s)
- Tamer Çelik
- Department of Pediatric Neurology; Adana Numune Research and Training Hospital; Adana Turkey
| | - Ümit Çelik
- Department of Pediatric Infection; Adana Numune Research and Training Hospital; Adana Turkey
| | - Mustafa Kömür
- Department of Pediatric Neurology; Adana Numune Research and Training Hospital; Adana Turkey
| | - Orkun Tolunay
- Department of Pediatrics; Adana Numune Research and Training Hospital; Adana Turkey
| | - Çiğdem Dönmezer
- Department of Pediatrics; Adana Numune Research and Training Hospital; Adana Turkey
| | - Dinçer Yıldızdas
- Department of Pediatric Intensive Care Unit; Cukurova University Faculty of Medicine; Adana Turkey
| |
Collapse
|
15
|
Celik U, Celik T, Tolunay O, Başpınar H, Kömür M, Levent F. Cerebral salt wasting in tuberculous meningitis: Two cases and review of the literature. Case Report. Neuro Endocrinol Lett 2015; 36:306-310. [PMID: 26454484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 01/19/2015] [Accepted: 01/19/2015] [Indexed: 06/05/2023]
Abstract
Cerebral salt wasting syndrome (CSWS) is characterized by severe natriuresis and volume depletion in the presence of cerebral pathology. In literature, there are few reports about tuberculous meningitis and cerebral CSWS. In this article, we report two tuberculous meningitis cases with CSWS and present a review of the literature on this topic. Cerebral salt wasting diagnosis was based on hyponatraemia associated with high urinary sodium excretion and inappropriately high urine output in the presence of dehydration. Treatment was made with sodium-fluid replacement plus fludrocortisone therapy in both cases. In agreement with the literature we argue that cerebral salt wasting syndrome might be more common than the syndromes of inappropriate antidiuretic hormone secretion (SIADH) in cerebral disorders. Differentiating the cerebral salt wasting syndrome from the SIADH is very important because unrecognized cerebral salt wasting syndrome can lead to inadequate management and result in unnecessary hyponatremia-related morbidity. The electrolyte and hydration status of patients should be monitored closely in patients with tuberculous meningitis.
Collapse
Affiliation(s)
- Umit Celik
- Pediatric Infection, Adana Numune Research and Training Hospital, Turkey
| | - Tamer Celik
- Pediatric Neurology, Adana Numune Research and Training Hospital, Turkey
| | - Orkun Tolunay
- Department of Pediatrics, Adana Numune Research and Training Hospital, Turkey
| | - Hüseyin Başpınar
- Department of Pediatrics, Adana Numune Research and Training Hospital, Turkey
| | - Mustafa Kömür
- Pediatric Neurology, Adana Numune Research and Training Hospital, Turkey
| | - Fatma Levent
- Department of Pediatrics, Texas Tech Health Sciences Center, USA
| |
Collapse
|
16
|
Gündoğdu G, Kömür M, Avlan D, Sarı FB, Delibaş A, Taşdelen B, Naycı A, Okuyaz C. Relationship of bladder dysfunction with upper urinary tract deterioration in cerebral palsy. J Pediatr Urol 2013; 9:659-64. [PMID: 22921013 DOI: 10.1016/j.jpurol.2012.07.020] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2012] [Accepted: 07/23/2012] [Indexed: 10/28/2022]
Abstract
Although lower urinary tract dysfunction (LUTD) in patients with cerebral palsy (CP) has been previously documented by clinical observations and urodynamic tests, its correlation with upper urinary tract deterioration (UUTD) has not been demonstrated. This paper documents symptoms and urodynamic findings of LUTD and their relationship with UUTD in 33 children with CP. By sonography, 4 of these children were found to have UUTD. Age was found to correlate with UUTD, but gender difference and mental or motor functions did not. When comparing urinary symptoms with UUTD, incontinence (n = 31) did not correlate, but on the other hand symptoms of detrusor sphincter dyssynergia (interrupted voiding, urinary retention, hesitancy; n = 5) and culture proven febrile urinary tract infections (n = 4) did. Abnormal urodynamics findings were not diagnostic. We conclude that, apart from incontinence, dysfunctional voiding symptoms and febrile urinary tract infections are valuable indicators of UUTD.
Collapse
Affiliation(s)
- Gökhan Gündoğdu
- Pediatric Surgery, Bezmialem Vakif University, Medical Faculty, Department of Pediatric Surgery, Division of Pediatric Urology, Istanbul 34093, Turkey.
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Arslanköylü AE, Kömür M, Uysal S, Erdoğan S. Çocuk Yoğun Bakım Birimi’nde önlenebilir kazalar nedeniyle izlenen hastalar. tpa 2012. [DOI: 10.4274/tpa.456] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
18
|
Bayram İ, Erbey F, Kömür M, Tanyeli A. Total Parenteral Nutrition and Decreased Dose Idarubicin Based Treatment of Acute Myeloid Leukemia During Childhood. ELECTRON J GEN MED 2010. [DOI: 10.29333/ejgm/82869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
19
|
Kömür M, Bayram İ, Erbey F, Küçükosmanoğlu O. A Rare Cause of Thrombocytopenia in
Infants: Vitamin B12 Deficiency. ELECTRON J GEN MED 2010. [DOI: 10.29333/ejgm/82831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
20
|
Tanyeli A, Erbey F, Bayram I, Kömür M. Myeloid antigen positivity in Turkish children with acute lymphoblastic leukemia lacks influence on prognosis. Asian Pac J Cancer Prev 2010; 11:1823-1826. [PMID: 21338240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
INTRODUCTION Several studies have suggested that the presence of myeloid antigens is a poor prognostic factor in patients with acute lymphoid leukemia (ALL). OBJECTIVE We aimed to assess this possibility in Turkish patients. MATERIALS AND METHODS Seventy-three children with a diagnosis of ALL-L1 and 38 with ALL-L2 were included. Flow cytometry and fluorescein-isothiocynate conjugated antibodies were used to determined surface antigens on blasts. RESULTS Myeloid antigens were positive in 48.4% with ALL-L1 and 60.5% with ALL-L2, the difference not being significant. Overall survival rates of myeloid antigen positive patients at 36, 60, and 72 months were 76%, 58%, and 48%, respectively, comparable to the corresponding 70%, 56%, and 46% in myeloid antigen negative patients (p >0.05). CONCLUSION We did not find any association between myeloid antigen positivity and clinical and laboratory features of ALL.
Collapse
Affiliation(s)
- Atila Tanyeli
- Department of Pediatric Oncology, Cukurova University Faculty of Medicine, Adana, Turkey
| | | | | | | |
Collapse
|
21
|
Bayram I, Erbey F, Kömür M, Kibar F, Tanyeli A. Flow cytometry results at diagnosis and relapse in childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev 2010; 11:1321-1324. [PMID: 21198285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
INTRODUCTION Several studies have focused on the immunophenotype of the leukemic population at the time of relapse compared to that observed at diagnosis. OBJECTIVE The question of whether differences exist between surface antigens levels on blasts at the time of diagnosis and at relapse in cases of acute lymphoblastic leukemia (ALL) was addressed. MATERIALS AND METHODS A total of 25 All patients were included. Flow cytometry and fluorescein-isothiocynate conjugated antibodies were used to determined surface antigens levels. RESULTS The most frequently detected five antigens were I2 (n=21), CD10 (n=17), CD41 (n=16), CD2 (n=14) and CD7/CD19 (n=13/n=13) at the time of diagnosis and CD41 (n=21), I2 (n=20), CD10 (n=14), CD19 (n=16) and CD2 (n=12) at the time of relapse. There was a significant difference only between CD41 levels at the time of diagnosis and at the time of relapse (p=0.041). CONCLUSION We found changes in antigen expressions at the time of relapse in ALL patients. This condition ought to be evaluated with reference to prognosis of leukemia.
Collapse
Affiliation(s)
- Ibrahim Bayram
- Division of Pediatric Oncology, Cukurova University Medical Faculty, Adana, Turkey
| | | | | | | | | |
Collapse
|
22
|
Kömür M, Erbey F, Bayram I, Tanyeli A. Incidence and prognostic importance of molecular genetic defects in children with acute myeloblastic leukemia. Asian Pac J Cancer Prev 2010; 11:1393-1395. [PMID: 21198299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
INTRODUCTION Acute myeloblastic leukemia (AML) accounts for 15 to 25 percent of childhood acute leukemias. The most common genetic abnormalities seen in pediatric AML patients are AML1-ETO, PML-RARα and CBFB-MYH11 genes resulting in t(8;21), t(15;17) and inv(16). These genetic defects are seen in approximately 20-25% of AML patients. OBJECTIVE We investigated in this study, incidence and prognostic significance of the AML1-ETO, PML-RARα and CBFB-MYH11 genes in children with AML. MATERIALS AND METHODS The authors analyzed 34 children with AML using the real time-polymerase chain reaction for AML1-ETO, PML-RARα and CBFB-MYH11 genes. RESULTS Of the patients, 8.8% were positive for t(8;21), 8.8% for t(15;17) and 3% for inv(16). There were a statistically significant differences between 48 month overall survival rates of the patients positive and negative for t(8;21), t(15;17) and inv(16). CONCLUSION It was concluded that t(15;17), t(8;21) and inv(16) impact on disease prognosis positively, but comprehensive studies with larger patient series are now needed for confirmation.
Collapse
MESH Headings
- Adolescent
- Child
- Child, Preschool
- Chromosomes, Human, Pair 15
- Chromosomes, Human, Pair 8
- Core Binding Factor Alpha 2 Subunit/genetics
- Female
- Humans
- Infant
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute/diagnosis
- Leukemia, Myeloid, Acute/epidemiology
- Leukemia, Myeloid, Acute/genetics
- Male
- Mutation/genetics
- Oncogene Proteins, Fusion/genetics
- Polymerase Chain Reaction
- Prognosis
- RUNX1 Translocation Partner 1 Protein
- Survival Rate
Collapse
Affiliation(s)
- Mustafa Kömür
- Department of Pediatric Oncology and Pediatric Bone Marrow Transplantaion Unit, Faculty of Medicine, Cukurova University, Adana, Turkey
| | | | | | | |
Collapse
|